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Outbreak of persistent cutaneous 
abscesses due to Mycobacterium 
chelonae after mesotherapy 
sessions, Lima, Peru
Surto de abscessos cutâneos 
persistentes por Mycobacterium 
chelonae pós-mesoterapia, Lima, Peru
ABSTRACT
Outbreaks of rapidly growing mycobacteria have been occasionally described. 
The article reports an outbreak of cutaneous abscesses due to Mycobacterium 
chelonae following mesotherapy in Lima, Peru. From December 2004 through 
January 2005, 35 subjects who had participated in mesotherapy training sessions 
presented with persistent cutaneous abscesses. Thirteen (37%) of  these suspected 
cases consented to underwent clinical examination. Skin punch-biopsies were 
collected from suspicious lesions and substances injected during mesotherapy 
were analyzed. Suspected cases were mainly young women and lesions included 
subcutaneous nodules, abscesses and ulcers. Mycobacterium chelonae was 
isolated from four patients and from a procaine vial. In conclusion, it is important 
to consider mesotherapy as a potential source of rapidly growing mycobacteria 
infections.
KEY WORDS: Mycobacterium chelonae. Mycobacterium infections, 
atypical. Disease outbreaks. Peru. 
RESUMO
Surtos de micobactérias de crescimento rápido têm sido relatados ocasionalmente. 
O estudo relata um surto de abscessos cutâneos por Mycobacterium chelonae 
após sessões de mesoterapia em Lima, Peru. De dezembro de 2004 a janeiro de 
2005, 35 pessoas que haviam passado por sessões de mesoterapia apresentaram 
esses abscessos cutâneos. Treze (37%) desses casos suspeitos concordaram 
em realizar exames clínicos. Foram realizadas biópsias de punção de pele de 
lesões suspeitas e examinadas substâncias injetadas durante a mesoterapia. Os 
casos suspeitos eram predominantemente mulheres jovens e as lesões incluíram 
nódulos subcutâneos, abscessos e úlceras. Mycobacterium chelonae foi isolada 
de quatro pacientes e de um frasco de procaína. Em conclusão, é importante 
considerar a mesoterapia como fonte potencial de infecções de micobactérias 
de crescimento rápido.
DESCRITORES: Mycobacterium chelonae. Infecções atípicas por 
Mycobacterium. Surtos de doenças. Peru.
147Rev Saúde Pública 2008;42(1):146-9
Although rapidly growing mycobacteria (RGM) are 
ubiquitous, diseases caused by these atypical bacteria 
are relatively uncommon.1 Among RGM, Mycobacte-
rium chelonae is particularly prominent. Clinical dise-
ases caused by this agent include cutaneous infections 
ranging from localized cellulitis to osteomyelitis. The 
precise burden of disease caused by this microorganism 
is unknown and most available information comes 
from occasional case reports. Cutaneous infections 
caused by RGM, including M. chelonae, have been 
associated with penetrating cutaneous trauma. Common 
procedures related to RGM-related infections included 
injections, liposuction, acupuncture and, more rarely, 
catheter insertions.1
Mesotherapy is an invasive procedure occasionally 
offered as “alternative medicine”. The technique in-
volves the intradermal injection of small amounts of 
diluted drug(s) and has been used to ameliorate pain and 
infl ammation and to improve “esthetical” conditions.2,5 
However, there is a paucity of evidence supporting the 
effi cacy of this procedure and its mechanism of action 
is unclear.5 As for other invasive procedures, adverse 
events associated to mesotherapy have been reported, 
including allergic reactions, atrophy, lipodystrophy, ble-
eding and systemic and local infections (HIV, hepatitis, 
atypical mycobacteria and pyodermitis).6
The present report describes the investigation of an 
outbreak of persistent cutaneous lesions after meso-
therapy in Lima, Peru.
METHODS
In December 2004, four patients presenting persistent 
cutaneous lesions were reported by the Alexander Von 
Humboldt Tropical Medicine Institute – Cayetano 
Heredia National Hospital to the General Direction 
of Epidemiology – Ministry of Health (GDE-MoH), 
Peru. The hospital laboratory had isolated RGM from 
lesion samples. All patients had attended mesotherapy 
training courses.
Two mesotherapy training courses preceded the outbre-
ak onset. Both courses took place in September 2004, 
approximately four months before the identifi cation of 
the fi rst case. Each mesotherapy course enrolled appro-
ximately 20-25 participants and both training courses 
included theory and practice sessions in which attendees 
injected/received injections to/from other attendees. 
These practices were supervised by a “cosmetologist,” 
who also provided the substances for the injections. 
Injectable vials recovered during the investigation 
included: L-carnitine, procaine, organic silicone and 
ascorbic acid. The procaine and L-carnitine vials had 
already been opened.
INTRODUCTION
An outbreak investigation was performed from De-
cember 2004 through January 2005, in Lima, Peru. 
A suspected case was defi ned as a person who had a 
persistent cutaneous lesion (duration > 2 weeks) and 
history of exposure to at least one mesotherapy session 
(as patient or trainee) within the last six months. A case 
was deemed as confi rmed when a positive culture for 
RGM was obtained.
Through the media, people were alerted on the poten-
tial association between mesotherapy and cutaneous 
lesions and attendees of mesotherapy sessions were 
encouraged to visit/contact their primary physicians for 
clinical evaluation. Clinicians of public/private health 
care centers in Lima were invited to report patients 
meeting the case defi nition to the GDE-MoH. A scre-
ening process was set up involving telephone contact 
and home visits by a research team. Suspected cases 
were interviewed using a structured questionnaire and 
skin punch-biopsies samples were collected. Suspected 
cases were invited for a specialized clinical examination 
and treatment at the Alexander Von Humboldt Tropical 
Medicine Institute.
Biological samples and injectable “mesotherapy-
substances” recovered during the investigation were 
analyzed at the laboratories of the National Institute 
of Health. Primary isolation of RGM was performed 
using BACTEC 460 TB in Middlebrook 12B medium. 
Growing colonies of RGM were typed based on growth 
rates and standard biochemical and enzymatic tests. The 
clonal relationship between fi ve mycobacterial isolates 
was determined through Enterobacterial Repetitive 
Intergenic Consensus (ERIC) PCR,6 using ERIC1R 
5’-ATGTAAGCTCCTGGGGATTCAC primers. DNA 
fi ngerprints cluster analyses of these isolates were 
performed using Gel Compar II version 4.0 package 
(Applied Maths, Kourtrai, Belgium).
Protection of patients’ privacy was emphasized throu-
ghout the study and informed consent was obtained.
RESULTS
Thirty-fi ve suspected cases were identifi ed. In addition 
to those persons who attended mesotherapy training 
courses, four additional suspected cases not directly 
linked to these courses were identifi ed. Two of them 
had received weight loss mesotherapy treatment by 
the same “cosmetologist” who directed the training 
courses and the other two patients had received treat-
ment from mesotherapy course “graduates,” but did 
not disclose the purpose of the received treatment. 
Overall, 13 (37%) suspected cases consented to parti-
cipate (including the four cases initially reported to the 
GDE-MoH). Cultures were performed in samples from 
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nine patients and M. chelonae was isolated from four 
cases. Among these confi rmed cases, three reported 
having attended the same mesotherapy course and one 
had attended a previous course (two weeks before) at 
the same institution.
Most suspected cases (11; 85%) were women and 
patients’ age ranged from 22 to 53 years. The median 
incubation period was approximately 16 days. The 
most common symptoms reported were fever (5; 40%), 
headache (5; 38%) and malaise (4; 33%). Subcutaneous 
nodules and abscesses were observed in 92% of the 
cases and skin ulcers in the remaining 8%. By the 
time of the evaluation, seven patients (54%) had had 
their abscesses drained and their lesions had turned 
into ulcers. Most lesions were located in the abdomen 
(62%) and face (40%) (Figure). The median number of 
injections received and lesions per subject were 60 and 
23, respectively. Organic silicone and procaine were 
the most commonly injected substances (11; 85%). M. 
chelonae was isolated from a procaine vial.
According to the amplifi cation patterns (N=5), DNA 
fi ngerprints from two isolates obtained from cases who 
attended the same mesotherapy course were clonally 
related. The other three isolates (from two cases and 
the procaine vial) showed similarities ranging from 
60% to 85%.
DISCUSSION
The study fi ndings are consistent with previous reports 
where M. chelonae was identifi ed as the causative 
agent of similar lesions in mesotherapy patients. Si-
milar infections have also been reported acupuncture 
treatment and insulin injections.3,7 A similar outbreak 
was documented during the same time period in the 
District of Columbia, United States. Cutaneous lesions 
were similar to the ones described in this report and M. 
chelonae was also isolated from biological samples.2
The source of contamination remains unclear. Injected 
substances might have been contaminated before use. 
In the present study, M. chelonae was isolated from 
one vial of procaine but this was opened by the time 
of sample collection and the DNA fi ngerprint of the 
isolated strain was not identical to others. Alternatively, 
RGM might have been inoculated during the injection 
procedure itself and different subjects were likely 
infected by bacteria that they were carrying on their 
skin. Nevertheless, although two of the isolates had 
identical DNA fi ngerprints, the remaining three isolates 
were clearly different. The identifi cation of the actual 
source of contamination will require further scrutiny.
The present study has some limitations. First, a case-
series study does not have a comparison group and 
the assessment of the putative exposure is usually pro-
blematic; therefore further analytical inferences were 
not possible. Second, the identifi cation of cases was 
based on a “willing-to-report” basis and moreover, the 
participation rate was low. Third, RGM are fastidious 
organisms and few isolates were obtained. However, 
the study observations are consistent with previous 
reports in the characteristics of clinical lesions and 
the isolated microorganism.2,4 The present research 
suggests a potential association between mesotherapy 
injections and persistent cutaneous abscesses in Lima, 
and warrant considerations on the safety of mesothe-
rapy practices.
Information supporting the effi cacy of mesotherapy is 
limited and reports of adverse effects are increasing 
as this practice gains popularity. Although regulations 
on mesotherapy practices vary from country to coun-
try, it is considered that, in Peru, mesotherapy must 
be performed by certifi ed health professionals and 
patients willing to undergo these procedures must be 
fully informed on the potential risks. It is important to 
consider mesotherapy as a potential source of RGM-
related lesions.
Figure. Cutaneous lesions on a 23-year-old female patient. 
Lima, Peru, 2004–2005.
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